Article
Anti-HBV Therapy in Hepatocellular Carcinoma May Affect the Symptoms of SARS-CoV-2 Infection
2023-05-22
Abstract excerpt
Background: Anti-HBV therapy is an important therapy for improving the prognosis of patients with HCC, but the effect of long term Entecavir (ETV) treatment on SARS-CoV-2 infection is not clear.<br><br>Methods: A total of 275 hepatocellular carcinoma (HCC) patients were included in the retrospective review. In the case of SARS-CoV-2 infection, the clinical symptom grading criteria were adopted from the ten edition...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 794afb63-5c5e-5c66-9eab-d655191c33cf
- DOI
- 10.2139/ssrn.4453488
